DNA (Hydroxy)Methylation in T Helper Lymphocytes

Trends in Biochemical Sciences

Volumn 44, Issue 7, 2019, Pages 589-598

  Monticelli, Silvia ^a  

^a INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; DNA;

ADAPTIVE IMMUNITY; CPG ISLAND; DNA DAMAGE RESPONSE; DNA DEMETHYLATION; DNA METHYLATION; DNA MODIFICATION; GENE EXPRESSION; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; CHEMISTRY; METABOLISM;

ANIMALS; DNA; DNA METHYLATION; HUMANS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 85061728130     PISSN: 09680004     EISSN: 13624326     Source Type: Journal    
DOI: 10.1016/j.tibs.2019.01.009     Document Type: Review

References (83)

1. Kanno, Y., et al. Transcriptional and epigenetic control of T helper cell specification: molecular mechanisms underlying commitment and plasticity. Annu. Rev. Immunol. 30 (2012), 707–731.
2. Wilson, C.B., et al. Epigenetic control of T-helper-cell differentiation. Nat. Rev. Immunol. 9 (2009), 91–105.
3. Sallusto, F., Monticelli, S., The many faces of CD4 T cells: roles in immunity and disease. Semin. Immunol. 25 (2013), 249–251.
4. Monticelli, S., MicroRNAs in T helper cell differentiation and plasticity. Semin. Immunol. 25 (2013), 291–298.
5. Grogan, J.L., et al. Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets. Immunity 14 (2001), 205–215.
6. Issuree, P.D., et al. Heritable gene regulation in the CD4:CD8 T cell lineage choice. Front. Immunol., 8, 2017, 291.
7. Rothenberg, E.V., Zhang, J.A., T-cell identity and epigenetic memory. Curr. Top. Microbiol. Immunol. 356 (2012), 117–143.
8. Baubec, T., Schubeler, D., Genomic patterns and context specific interpretation of DNA methylation. Curr. Opin. Genet. Dev. 25 (2014), 85–92.
9. Lister, R., et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462 (2009), 315–322.
10. Stadler, M.B., et al. DNA-binding factors shape the mouse methylome at distal regulatory regions. Nature 480 (2011), 490–495.
11. Okano, M., et al. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99 (1999), 247–257.
12. Bird, A., DNA methylation patterns and epigenetic memory. Genes Dev. 16 (2002), 6–21.
13. Li, E., et al. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69 (1992), 915–926.
14. Yang, L., et al. DNMT3A in haematological malignancies. Nat. Rev. Cancer 15 (2015), 152–165.
15. Xu, G.L., et al. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature 402 (1999), 187–191.
16. Tatton-Brown, K., et al. Mutations in the DNA methyltransferase gene DNMT3A cause an overgrowth syndrome with intellectual disability. Nat. Genet. 46 (2014), 385–388.
17. Ley, T.J., et al. DNMT3A mutations in acute myeloid leukemia. N. Engl. J. Med. 363 (2010), 2424–2433.
18. Smith, Z.D., Meissner, A., DNA methylation: roles in mammalian development. Nat. Rev. Genet. 14 (2013), 204–220.
19. Wu, X., Zhang, Y., TET-mediated active DNA demethylation: mechanism, function and beyond. Nat. Rev. Genet. 18 (2017), 517–534.
20. Schubeler, D., ESCI award lecture: regulation, function and biomarker potential of DNA methylation. Eur. J. Clin. Invest. 45 (2015), 288–293.
21. Bell, A.C., Felsenfeld, G., Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene. Nature 405 (2000), 482–485.
22. Domcke, S., et al. Competition between DNA methylation and transcription factors determines binding of NRF1. Nature 528 (2015), 575–579.
23. Yin, Y., et al. Impact of cytosine methylation on DNA binding specificities of human transcription factors. Science, 356, 2017, eaaj2239.
24. Liu, Y., et al. A common mode of recognition for methylated CpG. Trends Biochem. Sci. 38 (2013), 177–183.
25. Spruijt, C.G., et al. Dynamic readers for 5-(hydroxy)methylcytosine and its oxidized derivatives. Cell 152 (2013), 1146–1159.
26. Burger, L., et al. Identification of active regulatory regions from DNA methylation data. Nucleic Acids Res., 41, 2013, e155.
27. Baubec, T., et al. Genomic profiling of DNA methyltransferases reveals a role for DNMT3B in genic methylation. Nature 520 (2015), 243–247.
28. Neri, F., et al. Intragenic DNA methylation prevents spurious transcription initiation. Nature 543 (2017), 72–77.
29. Appanah, R., et al. An unmethylated 3′ promoter-proximal region is required for efficient transcription initiation. PLoS Genet., 3, 2007, e27.
30. Monticelli, S., Natoli, G., Short-term memory of danger signals and environmental stimuli in immune cells. Nat. Immunol. 14 (2013), 777–784.
31. Pastor, W.A., et al. TETonic shift: biological roles of TET proteins in DNA demethylation and transcription. Nat. Rev. Mol. Cell Biol. 14 (2013), 341–356.
32. Tahiliani, M., et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324 (2009), 930–935.
33. Tsagaratou, A., et al. TET Methylcytosine oxidases in T cell and B cell development and function. Front. Immunol., 8, 2017, 220.
34. Ko, M., et al. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature 468 (2010), 839–843.
35. An, J., et al. Acute loss of TET function results in aggressive myeloid cancer in mice. Nat. Commun., 6, 2015, 10071.
36. Bird, J.J., et al. Helper T cell differentiation is controlled by the cell cycle. Immunity 9 (1998), 229–237.
37. Leoni, C., et al. Epigenetics of T lymphocytes in health and disease. Swiss Med. Wkly., 145, 2015, w14191.
38. Lee, P.P., et al. A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity 15 (2001), 763–774.
39. Gamper, C.J., et al. Identification of DNA methyltransferase 3a as a T cell receptor-induced regulator of Th1 and Th2 differentiation. J. Immunol. 183 (2009), 2267–2276.
40. Schoenborn, J.R., et al. Comprehensive epigenetic profiling identifies multiple distal regulatory elements directing transcription of the gene encoding interferon-gamma. Nat. Immunol. 8 (2007), 732–742.
41. + T cells supports a linear differentiation model and highlights molecular regulators of memory development. Immunity 45 (2016), 1148–1161.
42. Komori, H.K., et al. Defining CD4 T cell memory by the epigenetic landscape of CpG DNA methylation. J. Immunol. 194 (2015), 1565–1579.
43. Ichiyama, K., et al. The methylcytosine dioxygenase Tet2 promotes DNA demethylation and activation of cytokine gene expression in T cells. Immunity 42 (2015), 613–626.
44. Tsagaratou, A., et al. Dissecting the dynamic changes of 5-hydroxymethylcytosine in T-cell development and differentiation. Proc. Natl. Acad. Sci. U. S. A., 111, 2014 E3306-15.
45. + T cells. Cell Rep. 16 (2016), 559–570.
46. Ko, M., et al. Ten-eleven-translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 14566–14571.
47. + T cell memory differentiation. J. Immunol. 200 (2018), 82–91.
48. Tsagaratou, A., et al. TET proteins regulate the lineage specification and TCR-mediated expansion of iNKT cells. Nat. Immunol. 18 (2017), 45–53.
49. Yue, X., et al. Control of Foxp3 stability through modulation of TET activity. J. Exp. Med. 213 (2016), 377–397.
50. Yang, R., et al. Hydrogen sulfide promotes Tet1- and Tet2-mediated Foxp3 demethylation to drive regulatory T cell differentiation and maintain immune homeostasis. Immunity 43 (2015), 251–263.
51. Amabile, A., et al. Inheritable silencing of endogenous genes by hit-and-run targeted epigenetic editing. Cell 167 (2016), 219–232.
52. Roth, T.L., et al. Reprogramming human T cell function and specificity with non-viral genome targeting. Nature 559 (2018), 405–409.
53. Seki, A., Rutz, S., Optimized RNP transfection for highly efficient CRISPR/Cas9-mediated gene knockout in primary T cells. J. Exp. Med. 215 (2018), 985–997.
54. Schafer, A., et al. Impaired DNA demethylation of C/EBP sites causes premature aging. Genes Dev. 32 (2018), 742–762.
55. Calo, E., Wysocka, J., Modification of enhancer chromatin: what, how, and why?. Mol. Cell 49 (2013), 825–837.
56. Wu, H., et al. Single-base resolution analysis of active DNA demethylation using methylase-assisted bisulfite sequencing. Nat. Biotechnol. 32 (2014), 1231–1240.
57. Bachman, M., et al. 5-Hydroxymethylcytosine is a predominantly stable DNA modification. Nat. Chem. 6 (2014), 1049–1055.
58. Lister, R., et al. Global epigenomic reconfiguration during mammalian brain development. Science, 341, 2013, 1237905.
59. Kim, H.S., et al. Pluripotency factors functionally premark cell-type-restricted enhancers in ES cells. Nature 556 (2018), 510–514.
60. Verma, N., et al. TET proteins safeguard bivalent promoters from de novo methylation in human embryonic stem cells. Nat. Genet. 50 (2018), 83–95.
61. Gu, T., et al. DNMT3A and TET1 cooperate to regulate promoter epigenetic landscapes in mouse embryonic stem cells. Genome Biol., 19, 2018, 88.
62. Tomkova, M., Schuster-Bockler, B., DNA modifications: naturally more error prone?. Trends Genet. 34 (2018), 627–638.
63. Tomkova, M., et al. 5-Hydroxymethylcytosine marks regions with reduced mutation frequency in human DNA. eLife, 5, 2016, e17082.
64. Montagner, S., et al. TET2 regulates mast cell differentiation and proliferation through catalytic and non-catalytic activities. Cell Rep. 15 (2016), 1566–1579.
65. Williams, K., et al. TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. Nature 473 (2011), 343–348.
66. Zhang, Q., et al. Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6. Nature 525 (2015), 389–393.
67. Buscarlet, M., et al. DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions. Blood 130 (2017), 753–762.
68. Zang, S., et al. Mutations in 5-methylcytosine oxidase TET2 and RhoA cooperatively disrupt T cell homeostasis. J. Clin. Invest. 127 (2017), 2998–3012.
69. Ballestar, E., et al. The epigenetic face of systemic lupus erythematosus. J. Immunol. 176 (2006), 7143–7147.
70. Bock, C., et al. Quantitative comparison of genome-wide DNA methylation mapping technologies. Nat. Biotechnol. 28 (2010), 1106–1114.
71. Lentini, A., et al. A reassessment of DNA-immunoprecipitation-based genomic profiling. Nat. Methods 15 (2018), 499–504.
72. Yu, M., et al. Base-resolution analysis of 5-hydroxymethylcytosine in the mammalian genome. Cell 149 (2012), 1368–1380.
73. Booth, M.J., et al. Quantitative sequencing of 5-methylcytosine and 5-hydroxymethylcytosine at single-base resolution. Science 336 (2012), 934–937.
74. Tsagaratou, A., Rao, A., TET proteins and 5-methylcytosine oxidation in the immune system. Cold Spring Harb. Symp. Quant. Biol. 78 (2013), 1–10.
75. Schutsky, E.K., et al. Nondestructive, base-resolution sequencing of 5-hydroxymethylcytosine using a DNA deaminase. Nat. Biotechnol., 2018, 10.1038/nbt.4204 Published online October 8, 2018.
76. Karemaker, I.D., Vermeulen, M., Single-cell DNA methylation profiling: technologies and biological applications. Trends Biotechnol. 36 (2018), 952–965.
77. Stricker, S.H., et al. From profiles to function in epigenomics. Nat. Rev. Genet. 18 (2017), 51–66.
78. Liu, X.S., et al. Editing DNA methylation in the mammalian genome. Cell 167 (2016), 233–247.
79. Vojta, A., et al. Repurposing the CRISPR–Cas9 system for targeted DNA methylation. Nucleic Acids Res. 44 (2016), 5615–5628.
80. Galonska, C., et al. Genome-wide tracking of dCas9-methyltransferase footprints. Nat. Commun., 9, 2018, 597.
81. Liu, X.S., et al. Rescue of fragile X syndrome neurons by DNA methylation editing of the FMR1 gene. Cell 172 (2018), 979–992.
82. Greally, J.M., A user's guide to the ambiguous word ‘epigenetics’. Nat. Rev. Mol. Cell Biol. 19 (2018), 207–208.
83. Vincenzetti, L.et al.(2019) The contribution of active and passive mechanisms of 5mC and 5hmC removal in human T lymphocytes is differentiation- and activation-dependent. Published online January 30, 2019. https://doi.org/10.1002/eji.201847967.